Nov 13, 2019 - Likelihood of a soon-to-be-signed U.S.-China trade deal, upbeat holiday season sales expectations and decent earnings have led the Nasdaq-100 ETF to a new high.
Nov 08, 2019 - Teva Pharmaceutical (TEVA) misses earnings estimate but beats the same for sales. The company increases the lower end of its 2019 sales and earnings guidance. Shares rise.
Nov 05, 2019 - MYL earnings call for the period ending September 30, 2019.
Nov 05, 2019 - Mylan N.V. (NASDAQ:MYL) Q3 2019 Earnings Conference Call November 05, 2019 10:00 AM ET Company Participants Melissa Trombetta - Head, Global Investor Relations Robert Coury - Chairman Heather Bresch -
Nov 05, 2019 - Mylan's (MYL) earnings beat estimates but sales miss the same in the third quarter of 2019. The company updates guidance for 2019.
Nov 04, 2019 - Let us take a look at five drug/biotech companies, which are supposed to release their quarterly results on Nov 5.
Oct 29, 2019 - Mylan (MYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 29, 2019 - Pfizer (PFE) beats estimates for third-quarter earnings and sales and raises earnings guidance range for 2019 while tightening revenue outlook.
Oct 24, 2019 - During Acorda's (ACOR) third-quarter earnings call, investor focus will be on the sales uptick of its newly launched Parkinson's disease drug Inbrija.
Oct 10, 2019 - Mylan (MYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.